Episoder
-
Podcast host Kelly Ulen interviews corresponding author Elias Chahine to discuss the latest advances in antiretroviral therapy (ART) research that investigates if there were differences in the safety and effectiveness of ART in White, Black, and Hispanic older people living with HIV. This podcast was filmed in November 2023 and coincides to the article of the same name published by Chahine and colleagues in the November issue of The Senior Care Pharmacist.
-
Podcast host, Kate Cozart, interviews Dr. Nicole Early to discuss the latest COPD guideline updates and the impact of senior care pharmacists on the management of COPD.
-
Mangler du episoder?
-
Podcast host, Kate Cozart, interviews Dr. Katie Boyd to discuss a case study involving concomitant use of CBD oil and antiplatelets. Guest host appearance by Hannah Holloway, PharmD Candidate
-
Join host, Donna Bartlett, PharmD, BGCP, as she interviews Patrick Russell, MD and Arduino Mangoni, FRACP regarding their two-part series, Rational Prescribing and Deprescribing of Antihypertensives Medications in Older Adults found in the March and April editions of TSCP Journal. Learn about the history of studies and sort out best practices for your patients.
-
Podcast host, Dr. Kelly Ulen, interviews Dr. Chris Alderman, Editor-In-Chief of The Senior Care Pharmacist journal. Dr. Alderman shares his top 10 tips to getting published. If you have thought about getting published, but don’t know where to start, this is the podcast to listen to!
-
Podcast host, Donna Bartlett, interviews Dr. Noll Campbell, Associate Professor of Pharmacy Practice at Purdue University and has an appointment with Indiana University Center for Aging Research about his guest editorial in January’s 2023 TSCP. Dr. Noll discusses his background in geriatrics and experiences in deprescribing including pathways and barriers to deprescribing.
-
Host, Dr. Donna Bartlett, speaks with Dr. Regina Ginzburg regarding a case study addressing medication issues and therapeutic inertia. Listen to this case about polypharmacy and deprescribing and the surprising number of recommendations.
-
This is a patient case exploring the importance of evaluating herbal and dietary supplements and how they may impact drug-drug and drug-gene implications based on pharmacogenomics test results. Even though herbal supplements are considered natural by many patients, which is often the reason for starting them, herbal supplements may still be metabolized by the same pathways as other medications, potentially contributing to drug-drug, drug-herb, and drug-gene interactions, and therefore, potentially impacting a patient’s response to medications.
-
Delirium is a syndrome that can arise from many causes or underlying conditions, and though it has been reported in younger patients, it is more prevalent in older people, though it can occur in other age groups as well. Identifying delirium is challenging in older people because of the coexistence of underlying dementia or depression, which may further complicate the presentation. Drug-induced delirium is one of the major causes of delirium, and evaluation of this potential cause or contribution is an important component of the evaluation process, since it can lead to poor patient outcomes. Part one of this three part series reviewed the epidemiology, pathophysiology, evaluation, diagnostic process, and causes of delirium in older people, with a focus on the pharmacological causes. Part two of this series continues to review drugs and drug classes that can cause or contribute to delirium in older people.
-
Inpatient falls continue to have detrimental effects on patient care and recovery. Because controllable and uncontrollable factors impact fall rates, predicting which patients are at the greatest risk can be challenging. One method includes the incorporation of student learners to help identify which patients are at the greatest risk for falls.
- Se mer
